Asset Details
Do you wish to reserve the book?
The value of gamma glutamyltransferase in predicting myocardial infarction in patients with acute coronary syndrome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The value of gamma glutamyltransferase in predicting myocardial infarction in patients with acute coronary syndrome
Do you wish to request the book?
The value of gamma glutamyltransferase in predicting myocardial infarction in patients with acute coronary syndrome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The value of gamma glutamyltransferase in predicting myocardial infarction in patients with acute coronary syndrome
2018
Overview
To assess the utility of gamma-glutamyl transferase (GGT) and C-reactive protein (CRP) in predicting troponin elevation in patients with acute coronary syndrome.
The total of 119 patients were divided into troponin-positive (n = 61) and troponin-negative (n = 58) patients.
CRP cut-off value ≥13.4 mg/l had the sensitivity of 68.1% and specificity of 62.5%, while the GGT cut-off value ≥61.5 IU/l had the sensitivity of 66.0% and specificity of 62.0% and combined use of both CRP and GGT had 71.4% sensitivity and 69.6% specificity in predicting troponin increase in acute coronary syndrome patients.
GGT might be used as an adjuvant marker for risk assessment patients who present with chest pain and are suspected to have acute coronary syndrome.
